Cargando…
The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction
Sodium-glucose cotransporter type 2 (SGLT2) inhibitors are a relatively new class of antihyperglycemic drug with salutary effects on glucose control, body weight, and blood pressure. Emerging evidence now indicates that these drugs may have a beneficial effect on outcomes in heart failure with reduc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010852/ https://www.ncbi.nlm.nih.gov/pubmed/33779401 http://dx.doi.org/10.1177/17539447211002678 |